WHO ICTRP trial
A pilot, multicenter, open-label, one-group study to explore the efficacy…
EUCTR2004-000463-94-HU · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2004-000463-94-HU |
|---|---|
| Public title | A pilot, multicenter, open-label, one-group study to explore the efficacy, tolerability and safety of an oral once-daily 600mg dose of glatiramer acetate (GA) in subjects with Relapsing Remitting (R-R) Multiple Sclerosis (MS). |
| Scientific title | A pilot, multicenter, open-label, one-group study to explore the efficacy, tolerability and safety of an oral once-daily 600mg dose of glatiramer acetate (GA) in subjects with Relapsing Remitting (R-R) Multiple Sclerosis (MS). |
| Primary sponsor | TEVA Pharmaceutical Industries Ltd. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Hungary;Italy |
| Conditions | Relapsing-remitting multiple sclerosis (R-R MS) MedDRA version: 5.1 Level: PT Classification code 10028245 |
| Interventions | Product Name: Glatiramer acetate 150mg enteric coated tablets Pharmaceutical Form: Coated tablet INN or Proposed INN: Glatiramer Acetate CAS Number: 147245-92-9 Current Sponsor code: COP-1 Other descriptive name: COP-1/Copolymer-1… |
| Registration date | Dec 7, 2004 |
| Target size | 25 |
| Secondary IDs | GA/7026 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: